Announcements Trials

Browse Landscape

Phase

Status

Completed 8 Unknown 3 Withdrawn 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 8 Polycystic Ovary Syndrome 7 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 6 Colorectal Neoplasms 5 Lung Neoplasms 4 Metabolic Syndrome 3 Insulin Resistance 3 Adenocarcinoma of Lung 3 Lymphoma, Large B-Cell, Diffuse 2 Glioblastoma 2 Carcinoma, Renal Cell 2 pCR Rate 1 Weight Gain 1 Thyroid Diseases 1 Thoracic Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Motor Activity 1 Melanoma 1 Lymphoma 1 Leukoplakia 1 Leukemia, Myelomonocytic, Acute 1

Interventions

Gemcitabine 100 130-nm albumin-bound paclitaxel 34 Oxaliplatin 28 Capecitabine 27 Fluorouracil 25 Albumin-Bound Paclitaxel 23 Leucovorin 19 Irinotecan 18 Erlotinib Hydrochloride 14 Cyclophosphamide 12 Radiosurgery 11 pembrolizumab 10 Radiotherapy 10 Nivolumab 10 Bevacizumab 10 Surgical Procedures, Operative 9 avelumab 7 Docetaxel 7 Taxes 6 Cisplatin 6 ruxolitinib 5 folfirinox 5 Specimen Handling 5 Paclitaxel 5 Everolimus 5 Cetuximab 5 ALT-803 5 trametinib 4 spartalizumab 4 fludarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pancreatic Neoplasms × Metformin × Clear all

NCT01167738 2015-04-24

PACT-17

IRCCS San Raffaele

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡